Hunan Fangsheng Pharmaceutical Co.Ltd(603998) board of supervisors
Verification opinions on the list of incentive objects first granted by the company’s restricted stock incentive plan in 2022
According to the provisions of the measures for the administration of equity incentive of listed companies (hereinafter referred to as the “measures”), the board of supervisors of Hunan Fangsheng Pharmaceutical Co.Ltd(603998) (hereinafter referred to as the “company”) checked the list of incentive objects granted restricted shares for the first time in the Hunan Fangsheng Pharmaceutical Co.Ltd(603998) 2022 restricted stock incentive plan (Draft) (hereinafter referred to as the “incentive plan (Draft)”, And give verification opinions on relevant situations as follows:
1. The list of incentive objects is consistent with the incentive objects determined in the incentive plan (Draft).
2. The basic information of the incentive object is true, and there is no falsehood, intentional concealment or major misunderstanding.
3. The incentive objects are the directors, senior managers, middle managers and core technology (business) backbone of the company (including subsidiaries) when the company implements the incentive plan (Draft).
4. None of the above personnel has any of the following circumstances:
(1) Being identified as an inappropriate candidate by the stock exchange within the last 12 months; (2) Those who have been identified as inappropriate candidates by the CSRC and its dispatched offices within the last 12 months;
(3) Being administratively punished by the CSRC and its dispatched offices or taking market entry prohibition measures for major violations of laws and regulations in the last 12 months;
(4) Those who are not allowed to serve as directors or senior managers of the company as stipulated in the company law;
(5) Those who are not allowed to participate in the equity incentive of listed companies according to laws and regulations;
(6) Other circumstances recognized by the CSRC
5. The incentive object does not have the situation that insider trading occurs due to the trading of the company’s shares or the disclosure of insider information.
6. There are no other circumstances in which the incentive object is prohibited from participating in the equity incentive plan. To sum up, after review, the board of supervisors of the company believes that the personnel listed in the list of incentive objects first granted by the company’s restricted stock incentive plan in 2022 have the qualifications specified in the company law, the articles of association and other laws, regulations and normative documents, and there is no case that they have been publicly condemned or declared as inappropriate candidates by the stock exchange in the past three years, There is no administrative punishment imposed by the CSRC for major violations of laws and regulations in the past three years, which meets the conditions of incentive objects specified in the management measures and the scope of incentive objects specified in the company’s incentive plan (Draft) and its abstract. Its subject qualification as the incentive object of the company’s equity incentive plan is legal and effective.
Hunan Fangsheng Pharmaceutical Co.Ltd(603998) board of supervisors March 4, 2022
